CIK 0001782303 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Boundless Bio, Inc.
Sign in to watch- Ticker
- BOLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830751369
- Phone
- (858) 766-9912
- Business address
- 11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $458,375
- in 5 filings
- Open-market sales, last 90 days
- $54,351
- in 1 filing
Net +$404,024. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-22 | Hornby Zachary President & CEO | Grant or award · Stock Option | +295,000 | 295,000 | ||
| 2025-01-22 | Oien Jessica See Remarks | Grant or award · Stock Option | +90,000 | 90,000 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Returned to the company · Stock Option | −10,256 | 0 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Returned to the company · Stock Option | −62,820 | 0 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Returned to the company · Stock Option | −94,871 | 0 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Returned to the company · Stock Option | −76,173 | 0 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Returned to the company · Stock Option | −48,703 | 0 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +10,256 | 10,256 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +62,820 | 62,820 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +94,871 | 94,871 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +76,173 | 76,173 | ||
| 2024-08-19 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +48,703 | 48,703 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −32,051 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −29,148 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −10,200 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −42,051 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −35,897 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −26,090 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Returned to the company · Stock Option | −16,234 | 0 | ||
| 2024-08-19 | Oien Jessica See Remarks | Grant or award · Stock Option | +32,051 | 32,051 |
Page 4 of 10 · 185 trades